Pharmaceutical compositions comprising a pH-dependent drug, a pH modifier and a retarding agent

Details for Australian Patent Application No. 2006284053 (hide)

Owner Novartis AG

Inventors Luckel, Barbara; Ries, Angelika; Siepe, Stefanie; Kramer, Andrea

Agent Davies Collison Cave

Pub. Number AU-B-2006284053

PCT Pub. Number WO2007/022956

Priority 0517204.4 22.08.05 GB; 0518359.5 08.09.05 GB

Filing date 22 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 22 April 2010

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/022956 Priority application(s): WO2007/022956

22 April 2010 Application Accepted

  Published as AU-B-2006284053

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284077-Use of azabicyclo hexane derivatives

2006283991-Rotor cover and electric motor